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In 10 anaesthetized cats, electroretinographic (ERG) measurements were carried out to further
elucidate the involvement of bradykinin as a substrate component of the renin-angiotensin system
in retinal neurotransmission. Reducing angiotensin II concentration by angiotensin-converting
enzyme (ACE)inhibition increased sensitivity [0.5 log units) and gain (50%) of the rod b-wave
amplitnde. The b-wave implicit time was decreased only at high stimulus intensities (>10–2 cd/m),
Blocking bradytdnin receptors specifically decreased rod b-wave implicit time for all intensities,
while its amplitude remained unaffected. Bradykinin effects were independent of alterations of
angiotensin II activity. We therefore suggest that bradyldnin influences inner retinal signal
processing, hereby further supporting the hypothesis of a renin-angiotensin system involvement in
retinal neurotransmission. Copyright K) 1996 Elsevier Science Ltd
Bradykinin Electroretinography Renin-angiotensin system Neurotransmission Intensity–
response function Angiotensin converting enzyme
INTRODUCTION
Bradykinin (BK) is a nonapeptidewith a wide range of
actionsthat havebeen extensivelyinvestigatedin isolated
organs, including the retina (Erdos, 1989; Taylor et al.,
1989). BK is known to influence vascular permeability,
tonus of smooth muscle cells and by activation of
phospholipase-A2,BK has alsobeen shownto be a potent
stimulator of prostaglandin and leukotriene synthesis
(Griesbacher & Lembeck, 1989; Zusmann, 1987). By
stimulating nociceptive afferent nerve fibres BK en-
hances pain and hyperalgesia (Steranka et al., 1987).
However, not much is known whether BK—as many
other peripherally active peptides—is also involved in
modulatingneuronalactivity,more specifically in retinal
neurotransmission.
BK is inactivated by the angiotensin converting
enzyme (ACE) and thus closely related to the renin–
angiotensin system (Fig. 1). Recent studies have
suggested that various components of the renin–angio-
tensin system(RAS) are involvedin modulatingneuronal
activity in the central nervoussystem(Severs & Daniels-
Severs, 1973; Brecha, 1983; Brecha et al., 1981; Felix,
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1982;Kolb & Nelson, 1983;Lind et al., 1985;Sessle &
Henry, 1987; Story & Ziogas, 1987; Watt & Su, 1988;
Morgan, 1989;Morgan et al., 1989;Ferrari-Dileo et al.,
1988). Moreover, immunocytochemicaland electroreti-
nographicaldata provided experimental evidence of the
RAS also participating in retinal neuromodulation
(Dahlheim et al., 1988; Mallorga et al., 1989; Zrenner
et al., 1989;Datum & Zrenner, 1991;Kohleret al., 1992;
Jurklies et al., 1993;Jacobi et al., 1992, 1994;Kaelin et
al., 1994).A possiblerole of BK in retinalphysiologyhas
so far not been investigated.
Recent experiments revealed that inhibition of ACE
induces changes of electroretinographicpotentialsorigi-
nating in the inner retina, while outer retina signals
remainunaffected(Jacobiet al., 1992,1994).To a certain
extent some of these effects were reversible on
angiotensin-11(ANGII) substitution, thus indicating an
ANGII-mediated influenceon ERG responses (Jacobi et
al., 1992, 1994). However, blocking ACE action
simultaneously changes the metabolism of other pep-
tides, including BK (Fig. 1). As ACE catalyses both
substrates—it increases the formation of ANGII but
inactivatesBK—it seems difficultto assign the observed
effects of ACE inhibitionto a single substrate.
The aim of this study was to further elucidate a
possibleANGII influencefrom a BK-mediated effect on
the electroretinogram(ERG)in anaesthesized cats. For
this reason we applied a specificBK receptor antagonist
(Hoeldo)prior to ACE inhibition(Quinapril).An increase
in BK concentration following ACE inhibition should
then have no neurobiochemicalinfluenceat the receptor
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FIGURE 1. The angiotensin–reninsystem and the interactionswith other peptides found in the retina of various species. The
competitive ACE inhibitor Quinapril reduces the catalysis of the physiologically active octapeptide angiotensin-II and
inactivates bradykininsimultaneously.Hoeldois a specific BK receptor blocker with no intrinsic activity.
site. The pharmacokinetics and -dynamics of ANGII,
however, are not influencedby preceding applicationof
the BK receptor blocker. We can, therefore, assume that
differences in effects on ERG responses of single ACE
inhibition on the one hand, and of ACE inhibition in
conjunctionwith BK receptorblockadeon the other may
be due to a BK-mediatedaction. Since bradykinincan be
shown to have a specific influence on electroretino-
graphic responses, this study provides further evidence
for the involvementof the RAS in retinal neuromodula-
tion.
METHODS
Preparations and recordings were carried out as
described in detail previously (Jacobi et al., 1994). All
animals were treated according to the resolution of the
European CommunitiesCouncil Directive (1986) on the
Use of Animals in Research.Anesthesia was initiatedby
an i.m. injectionof ketamine and thiaminehydrochloride
(3:2; 0.15 mg/kg) in 10 adult cats. Animals were then
intubated and carefully monitored for respiration and
circulation parameters. Arterial blood pressure was
monitored on-lineby means of a femoral artery catheter.
A femoral” vein catheter was used’for iv. drug appli-
cation. By repeated intravenous injections (0.1 ml) of
pentobarbital (Nembutal 60 mg/ml) the maintainanceof
anesthesia was ensured.
The ERG was recorded by means of corneal contact
lens electrodes (ERG Jet Electrode) with pupils fully
dilated. Subdermalelectrodesplaced at the forehead and
the front leg served as indifferentand ground electrodes,
respectively. The luminance of a Ganzfeld-stimulator
(LKC, Utas 2000) was attenuated by neutral density
filters (Kodak Wratten). All measurementswere carried
out in the dark-adapted state and stimulus luminance
ranged from b-wave threshold to saturation (l.5*10–2–
2.4 cd+/m2) using a 150 W Xenon flash light (lambda=
508 nm; duration: 10 ~sec).
For ACE inhibition Quinapril (Parke-Davis) disolved
in 0.9’%salinewas intravenouslyinjected at a concentra-
tion of 4 mg/kg. In five animals the specificbradykinin
receptor blocker Hoe140(Hoechst AG) was injected (1
mg/k ) 2 hr prior to ACE inhibition. H6e140(D-Arg-8 .5[Hyp ,Thl ,D-Tic7,0ic8]-bradykinin)is a highly potent,
competitiveBK antagonist,specificto BK receptors and
with no intrinsicactivity (Hock et al., 1991;Wirth et al.,
1991). Electrophysiologicaldata were recorded several
timesbefore and after applicationof the drugs.Statistical
analysis was performed using the non-parametric Wil-
coxon test.
RESULTS
Arterial blood pressure
The ACE inhibitorQuinaprilregularlycauseda drop in
mean arterial blood pressure (MAP), irrespective of the
presence of Hoe140.The relative reduction in MAP was
greatest (42 ~ 17mmHg) at 90 min after the injection
and lasted for another 30-60 min. Hoe140,on the other
hand, did not lead to MAP changes.
Scotopic b-wave
The effects of the ACE inhibitor Quinapril and the
speci”ficBK receptor blocker Hoe140on the scotopic b-
wave amplitude are demonstrated in Fig. 2. The
amplitudes of the b-waves were plotted against the
logarithm of integral luminance of the stimulus, pre-
sented for 17)psec at a fixed stimulus interval of 5 sec
after dark adaptation for at least 90 min. The intensity–
response functions (V—logI) obtained before drug
application (solid circles) follows a typical sigmoidal
course.An increase of irradiancebeyond 2 or 3 log units
abovethe b-wave threshold,producesa dmp in amplitude
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FIGURE 2. (a) Effects of the ACE inhibitor Quinapril (soIid diamonds)on the b-wave amplitude of the scotopic intensity–
response function. Quinapril was injected at a dose of 4 mg/kg. Responses presented here were recorded 90 min after the
injection of Quinapril.ACE inhibitionincreases sensitivity(0.5 log units) and gain (50Y~)of all resPonses.Q@wildoesnot
alter the typical sigmoidalcourse and the dip between the two rising phases of the control (solid circles) recordedbefore ACE
inhibition (n= 5; mean f SEM). (b) The application of Hoelw does not affect the b-wave amplitude. Subsequent ACE
inhibition results in the same amount of increase in b-wave sensitivity and gain as seen without prior BK blockade, thus
indicatingan ANGII-mediatedeffect. Hoeldowas injected at a doseof 1mg/kg.Responsespresentedherewere recorded90 min
(Hoe140)and 160min (Hoel,o and Qqinapril)afterthedmg injections (n=5; mean * SEM).
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between two rising phases. The second rising phase is
considered to be generated by cones (Arden et al., 1960;
van Lith, 1966)whereas the dip between them is thought
to be a result of interactions within the rod pathway
(Olsen et al., 1986).Quinaprilresults in an increaseof the
b-wave amplitude.The V –logI functionalso shiftsto the
left and becomes steeper [diamonds in Fig. 2(a)]. Both
effects indicate an overall increase in sensitivity(0.5 log
units) and gain (5070). Changes in amplitude were
significant (P < 0.05). These results are indicative of
an ANGII involvementin affecting the scotopicb-wave
amplitude.However,the broad substratespecificityof the
ACE raises the question of an involvement of various
other ACE substrates. As ACE inhibition not only
reduces the ANGII activity but also increases the BK
concentration via reduced BK inactivation, in a second
series of experiments we injected the BK receptor
blocker HoelAOprior to ACE inhibition [Fig. 2(b)].
Hoelqo is a competitive receptor blocker with a high
affinity to BK receptors. The systemic halftime value
exceeds4 hr (Wirth et al., 1991).The injectionof Hoe140
itself does not affect the scotopic b-wave amplitude
[diamonds in Fig. 2(b)]. However, subsequent ACE
inhibition leads to an increase in amplitude comparable
with thoseexperimentswhere no BK receptorblockerhas
been applied [solid triangles in Fig. 2(b)]. Consequently,
effects of ACE inhibition on the ERG amplitude under
these circumstancesare likely to be mediated solely via
the RAS without involvementof BK.
The implicit time of the scotopicb-wave showsa quite
differentbehaviour (Fig. 3). ACE inhibitionshortensthe
implicit time as one could expect from the amplituderise
in Fig. 2. Responseselicited 2.5 log units above threshold
are reduced by Quinapril by approximately 119%[solid
diamonds in Fig. 3(a)]. The difference is statistically
significant (P < 0.05). Responses obtained at lower
stimulus irradiances are not affected significantly. In
contrast to the b-wave amplitude, the implicit time is
altered by Hoe140application. The implicit time of the
whole V—logI function is reduced significantly (P <
0.05) by Hoe140[diamonds in Fig. 3(b)]. Subsequent
ACE inhibition does not result in further changes [solid
triangles in Fig. 3(b)]. In summary, the BK receptor
blockade does not affect the scotopicb-wave amplitude,
nor does it change the Quinapril induced effect on the b-
wave amplitude.However, there is a marked influenceof
Hoe140on the implicit time, strongly suggesting a BK
involvement in the time domain of ERG b-wave
generation.
Scotopic a-wave
At a stimulusluminanceof 2.4 cd/m2,influenceson the
scotopic a-wave were also evaluated. Before drug
application mean ( + SD) amplitude and implicit time
were 175 i 23 pV and 13 + 1.3msec, respectively.The
course of the a-wave remains unaltered throughout the
entire experiment. The,a-wave reflecting activity of the
outer retina is not affected by ACE inhibition, BK
receptorblockadeor by the combinationof Quinapriland
Hoelqo application. This observation might point to a
specific influence of the pharmacological alterations on
the different layers of the retina.
Hertz jlicker
In order to obtain a cone responsewithout exposureto
extensive light adaptation, a 30 Hz red flicker was
recorded. Prior to drug administration, amplitude and
implicit time are 14.6,aV(-J 4.7 pV SD) and 59.3 msec
(+ 12.4 msec SD), respectively. The 30 Hz flicker
amplitude and latency were not affected by ACE
inhibition,BK receptor blockade or by the combination
of Quinapriland Hoe140application.The data from the 30
Hz red flicker response indicate that the cone pathway is
not as involved in a hypothetical RAS-mediated
neuromodulatoryprocessin the retina as the rod pathway.
DISCUSSION
The present results support the evidence that the
observed effects of intravenously applied bradykinin
inhibitor Hoe140and subsequentACE inhibitionQuina-
pril on the cat electroretinogram represent actions of
modulation within the angiotensin–bradykininmetabo-
lism on retinal neurotransmission. We previously re-
ported that ANGII is present in the neuroretina,affecting
amplitude and implicit time of electroretinographic
responses (Zrenner et al., 1989; Jacobi et al., 1994). In
the present study we have extended those findings by
recording ERG responses under specific BK receptor
blockade,supportingthe notionof a RAS involvementin
retinal neurotransmission.Both BK, as well as ANGII,
are substratesof ACE—thekey enzymeof the RAS-and
have been reported to occur in various ocular tissues of
human, feline, bovine and cat (Ferrari-Dileoet al., 1988;
Kaelin et al., 1994). Undoubtedly, there is evidence
(Igemoto & Yamamoto, 1978; Igic & Kojovic, 1980)
indicating that an ocular renin–angiotensinsystem may
exist. However, the precise localization of the compo-
nents of the RAS and the sites for synthesisand activity
still remain unclear, especially concerning neuroretinal
activity (Ferrari-Dileo et al., 1987, 1988; Danser et al.,
1989;Strittmatteret al., 1989;Deinum et al., 1990).
In a previousstudy, inhibitionof ACE by Quinapril in
anaesthesized cats resulted in distinct changes of ERG
responsesoriginatingin the inner retina, which were to a
certain extent reversible on ANGII supplementationand
notexplainedby its effectson the vascularsystem(Jacobi
et al., 1994;Demant et al., 1982;Niemeyeret al., 1982).
Signals originating in the outer retina (PIII) remained
unaffected (Jacobi et al., 1994). This strongly points
towards a modulatory effect of ANGII on retinal
neurotransmission. Since ACE converts a number of
substrates it is conceivable that other substrates such as
BK may also be present in the neuroretina, thereby
characterizingACE rather than other substratesas being
of importance in the course of modulating retinal
processing.
The present results support this hypothesis. The
application of a specific BK blocker (Hoe140)does not
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scotopicintensity–responsefunction.’In the control,increasingstimulusluminanceleads to the expecteddecreaseof the b-wave
implicit time (solidcircles). ACE inhibitionresults in a furtherreduqtionof’theitiplicit time for responsesrecordedat stimulus
luminance =10- 2cd/m2.(b)The applicationof Hoe140significantlyreduces the b-wave’implicittime at all stimulus intensities
between 12and 20%.’SubsequentQuinaprilinjectiondoes not leadto further changes.These results are stronglyindicativeof a
BK-mediatedeffect on the scotopic b-wave implicit time. ,,:
, ! ;::,.. :,,.
3848 P. C. JACOBI et al.
affect the a-wave but has some effect on the b-wave.
Depolarizing bipolar cells possibly are the neuronal
origins of this response and, therefore, ought to be
considered as a probable site of action. However, effects
on the b-wave implicit time could also be interpreted as
amacrine cell-mediated. Subpopulations of amacrine
cells increase the time course of rod signals (Nelson,
1982). Again there is immuncytochemical evidence to
support these assumptions,since specificANGII binding
sites have been revealed in a subpopulationof amacrine
cells in chicken (Datum & Zrenner, 1991).
An influenceof bradykininon the depolarizingbipolar
cells has to be considered in conjunction with Miiller
cells, sinceboth contributeto the formationof the b-wave
(Miller & Dowling, 1987). The Mi,illercell/K+-hypoth-
esis of b-wave generation implies that the light-evoked
increase in extracellular [K+] in the outer and inner
plexiform layers results in an influx of [K+]into Muller
cells,which in turn resultsin a radial currentflowthrough
the cells that can be picked up by corneal electrodes
(Miller & Dowling, 1987; Kuffler, 1967; Faber, 1969).
The [K+]increase in the outer plexiform layer is mainly
generated by the depolarizingbipolar cells and predomi-
nates in generatingthe response(Faber, 1969;Dick et al.,
1985; Stockton & Slaughter, 1989). Thus, the b-wave
may reflect indirectly the activity of the depolarizing
bipolar cells and the observed alterations could be
explained by some kind of neuronal influence of the
RAS on these cells.
However, since IK+]-metabolismin the Miiller cell is
most probably responsiblefor the b-wave modulationof
Mi.tilercell function itself, alterationsshould show up in
the ERG (Kuffler, 1967). Neuropharmacologicalactions
on Mi.illercells would alter neurotransmission in the
retina as well, but in a more global manner since glial
cells rather than individualneurons are involved.A glial
cell-mediated mechanism on the extracellularpotassium
level, thereforecould play a role in the BK effect as well.
The probability of the observed ERG alterations
simplybeing due to variationsin systemicbloodpressure
is very low. Demant et al. (1982) convincinglyshowed
that variations in the systemic arterial blood pressure
have no effect on the b-wave of the cat electroretinogram.
Autoregulation of retinal circulation has therefore been
postulated (Niemeyer et al., 1982). We confirmedthese
results by reducing the mean arterial blood pressure
(MAP) by means of dihydralazine injections (Jacobi et
al., 1994); ERG responses remained stable even when
lowering the MAP to 60 mmHg. This notion of a MAP-
independent influence is further supported by the
observation that the a-wave—representing activity in
the outer retina—is not affected by changes in BK or
ANGII activity, while responses generated in inner
retinal layers (b-wave) are influenced.,Finally, it should
be mentioned, that in spite of the presumed autoregula-
tion, a local ocular circulation-retinal or choroidal in
particular-could theoreticallybe affectedby the applied
neuropeptides, which would occur undetected by our
experiments.
In summary, the results presented here support a
hypothesisof RAS involvementin retinalneurotransmis-
sion that is not linked to its systemicvasoactive effects,
since: (1) inner retina (b-wave) and not outer retina
responses (a-wave) are affected; (2) subsequent to
previously reported ANGII effects we can now report
on experiments with a BK-mediated influence on
mammalian ERG with no effects on systemic blood
pressure;(3) the amplitude-increasingeffect of Quinapril
is not alteredby previousBK receptorblockade;(4) these
results are in accordancewith immunohistochemicaland
in vitro electroretinographicstudies that point to inner
neuroretina involvement.Whatever the possible cellular
originmightbe, these in vivo experimentsfurther support
evidenceof the renin–angiotensinsystembeing involved
in retinal neuromodulation, which shows up in the
Ganzfeld ERG.
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